Applied DNA Sciences Inc.

6.02-0.2800-4.44%Vol 171.02K1Y Perf 9.27%
Apr 19th, 2021 13:50 DELAYED
BID5.99 ASK6.05
Open6.22 Previous Close6.30
Pre-Market6.26 After-Market-
 -0.04 -0.63%  - -
Target Price
18.67 
Analyst Rating
Strong Buy 1.00
Potential %
210.65 
Finscreener Ranking
★+     45.14
Insiders Trans % 3/6/12 mo.
-100/-100/41 
Value Ranking
     42.28
Insiders Value % 3/6/12 mo.
-100/-100/151 
Growth Ranking
★★     44.38
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/77 
Income Ranking
 —    -
Market Cap44.99M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
9.35 
Earnings Date
13th May 2021

Today's Price Range

5.966.40

52W Range

4.9516.39

5 Year PE Ratio Range

-3.40-1.90

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-11.27%
1 Month
-26.66%
3 Months
-42.73%
6 Months
-18.18%
1 Year
9.27%
3 Years
-89.21%
5 Years
-94.89%
10 Years
-95.39%

TickerPriceChg.Chg.%
APDN6.02-0.2800-4.44
AAPL134.490.33000.25
GOOG2 300.002.24000.10
MSFT258.59-2.1500-0.82
XOM56.16-0.5000-0.88
WFC44.130.29000.66
JNJ162.21-0.0300-0.02
FB302.12-4.0600-1.33
GE13.38-0.0100-0.07
JPM153.17-0.1300-0.08
Financial StrengthValueIndustryS&P 500US Markets
1.80
2.20
0.03
0.15
-158.50
Leverage Ratio 1.80
ProfitabilityValueIndustryS&P 500US Markets
74.90
-455.50
-445.00
-339.10
-
RevenueValueIndustryS&P 500US Markets
2.36M
0.32
-20.33
-16.57
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.55-0.62-12.73
Q04 2020-0.59-0.82-38.98
Q03 2020-0.62-0.72-16.13
Q02 2020--0.79-
Q01 2020--1.12-
Q04 2019--1.44-
Q03 2019--1.60-
Q02 2019--3.20-
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.1722.73Positive
6/2021 QR0.03-57.14Negative
9/2021 FY-0.40-42.86Negative
9/2022 FY0.63--
Next Report Date13th May 2021
Estimated EPS Next Report-0.17
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume171.02K
Shares Outstanding7.47M
Trades Count1.24K
Dollar Volume12.33M
Avg. Volume1.39M
Avg. Weekly Volume197.74K
Avg. Monthly Volume764.12K
Avg. Quarterly Volume825.81K

Applied DNA Sciences Inc. (NASDAQ: APDN) stock closed at 6.3 per share at the end of the most recent trading day (a -3.37% change compared to the prior day closing price) with a volume of 123.49K shares and market capitalization of 44.99M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 61 people. Applied DNA Sciences Inc. CEO is James A. Hayward.

The one-year performance of Applied DNA Sciences Inc. stock is 9.27%, while year-to-date (YTD) performance is 23.53%. APDN stock has a five-year performance of -94.89%. Its 52-week range is between 4.95 and 16.39, which gives APDN stock a 52-week price range ratio of 9.35%

Applied DNA Sciences Inc. currently has a PE ratio of -2.30, a price-to-book (PB) ratio of 9.65, a price-to-sale (PS) ratio of 20.98, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -141.06%, a ROC of -190.33% and a ROE of -223.11%. The company’s profit margin is -%, its EBITDA margin is -445.00%, and its revenue ttm is $2.36 Million , which makes it $0.32 revenue per share.

Of the last four earnings reports from Applied DNA Sciences Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.17 for the next earnings report. Applied DNA Sciences Inc.’s next earnings report date is 13th May 2021.

The consensus rating of Wall Street analysts for Applied DNA Sciences Inc. is Strong Buy (1), with a target price of $18.67, which is +210.65% compared to the current price. The earnings rating for Applied DNA Sciences Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Applied DNA Sciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Applied DNA Sciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 18.78, ATR14 : 0.94, CCI20 : -135.17, Chaikin Money Flow : -0.56, MACD : -0.92, Money Flow Index : 71.26, ROC : -11.27, RSI : 39.80, STOCH (14,3) : 2.14, STOCH RSI : 0.25, UO : 29.79, Williams %R : -97.86), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Applied DNA Sciences Inc. in the last 12-months were: Scott L. Anchin (Option Excercise at a value of $56 240), Scott L. Anchin (Sold 13 049 shares of value $110 042 ), William W. Montgomery (Buy at a value of $-541 616)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a provider of DNA-based supply chain, anti-counterfeiting, and anti-theft technology. The company provides its products and services under the brand of SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. It serves clients in various industries including government/military, security and asset marking, industrial parts, pharmaceuticals, textiles and apparel, and printing and packaging. The company has operational footprints across the United States, Europe, Asia, and others.

CEO: James A. Hayward

Telephone: +1 631 840-8800

Address: 50 Health Sciences Drive, Stony Brook 11790, NY, US

Number of employees: 61

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

45%55%

Bearish Bullish

68%32%

News

Stocktwits